Adiponectin is markedly increased in patients with nephrotic syndrome and is related to metabolic risk factors Carmine Zoccali, Francesca Mallamaci,

Slides:

Advertisements

Similar presentations

Vitamin D levels and patient outcome in chronic kidney disease

Advertisements

Volume 68, Issue 3, Pages (September 2005)

Volume 70, Issue 4, Pages (August 2006)

Erythropoietin should be part of congestive heart failure management

The overdriven glomerulus as a cardiovascular risk factor

Linear and logistic regression analysis

Anemia management in chronic kidney disease

Erythropoietin should be part of congestive heart failure management

Volume 83, Issue 3, Pages (March 2013)

Lipopheresis in the nephrotic syndrome

Francesco Locatelli, Lucia Del Vecchio, Simeone Andrulli, Sara Colzani

Volume 61, Issue 2, Pages (February 2002)

Progression of renal failure and hypertensive nephrosclerosis

John P. Middleton, Patrick H. Pun Kidney International

The overdriven glomerulus as a cardiovascular risk factor

Burden of chronic kidney disease: North Africa

Francesco Paolo Schena Kidney International

Jeffrey C. Fink, Glenn M. Chertow Kidney International

George A. Kaysen, Burl R. Don

Volume 66, Pages S13-S17 (September 2004)

Volume 67, Issue 6, Pages (June 2005)

Comorbidity and confounding in end-stage renal disease

Volume 74, Issue 3, Pages (August 2008)

Volume 70, Issue 11, Pages (December 2006)

Body weight is a fluctuating parameter in hemodialysis patients

D. Coyne Kidney International Volume 69, Pages S1-S3 (May 2006)

The epidemiology of chronic kidney disease

G. Tripepi, K.J. Jager, F.W. Dekker, C. Wanner, C. Zoccali

Edmund G. Lowrie Kidney International

Study of Heart and Renal Protection (SHARP)

Volume 74, Issue 8, Pages (October 2008)

Volume 71, Issue 6, Pages (March 2007)

Volume 59, Issue 4, Pages (April 2001)

Volume 67, Pages S48-S51 (January 2005)

Fructose intake as a risk factor for kidney stone disease

Volume 73, Issue 12, Pages (June 2008)

New insights in uremic toxins

Vitamin D levels and patient outcome in chronic kidney disease

Volume 69, Issue 12, Pages (June 2006)

Volume 69, Issue 3, Pages (February 2006)

Non-immunologic intervention in chronic allograft nephropathy

Nephrology in Latin America, with special emphasis on Brazil

AGEs in foods: Do they play a role in uremia?

Volume 53, Issue 4, Pages (April 1998)

Simvastatin in nephrotic syndrome

Counteracting progression of renal disease: A look into the future

Volume 71, Issue 4, Pages (February 2007)

Homocysteine, renal function, and risk of cardiovascular disease

Yasunori Kitamoto, Katsuhiko Matsuo, Kimio Tomita Kidney International

Volume 62, Issue 1, Pages (July 2002)

Carmine Zoccali, Francesca Mallamaci Kidney International

Volume 71, Issue 6, Pages (March 2007)

Taking a public health approach to the prevention of end-stage renal disease: The NKF Singapore Program Sylvia Paz B. Ramirez, Stephen I-Hong Hsu, William.

Clinical benefits of slowing the progression of renal failure

Low triiodothyronine and survival in end-stage renal disease

Volume 72, Issue 2, Pages (July 2007)

Volume 61, Issue 2, Pages (February 2002)

Volume 80, Issue 10, Pages (November 2011)

Volume 70, Issue 4, Pages (August 2006)

Volume 74, Issue 9, Pages (November 2008)

Effect of proteinuria and glomerular filtration rate on cardiovascular risk in essential hypertension Julian Segura, Carlos Campo, Luis M. Ruilope Kidney.

Is it the low-protein diet or simply the salt restriction?

Charles A. Herzog Kidney International

Volume 71, Issue 12, Pages (June 2007)

Membranous nephropathy: recent travels and new roads ahead

Volume 68, Issue 3, Pages (September 2005)

Relationship between advanced glycoxidation end products, inflammatory markers/acute-phase reactants, and some autoantibodies in chronic hemodialysis.

Volume 57, Pages S44-S48 (April 2000)

Asymmetric dimethylarginine: A cardiovascular risk factor in renal disease? Danilo Fliser, Jan T. Kielstein, Hermann Haller, Stefanie M. Bode-Böger Kidney.

Peter Stenvinkel, Olof Heimbürger, Catherine H. Tuck, Lars Berglund

Presentation transcript:

Adiponectin is markedly increased in patients with nephrotic syndrome and is related to metabolic risk factors Carmine Zoccali, Francesca Mallamaci, Vincenzo Panuccio, Giovanni Tripepi, Sebastiano Cutrupi, Saverio Parlongo, Francesco Catalano, Sachiyo Tanaka, Noriyuki Ouchi, Shinji Kihara, Tohru Funahashi, Yuji Matsuzawa Kidney International Volume 63, Pages S98-S102 (May 2003) DOI: 10.1046/j.1523-1755.63.s84.49.x Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 1 Relationship between plasma ADPN (expressed as lg10) and 24-hour proteinuria, serum cholesterol, and serum albumin in 41 patients with chronic renal diseases. Data are shown as Pearson product moment correlation coefficients and P values. Kidney International 2003 63, S98-S102DOI: (10.1046/j.1523-1755.63.s84.49.x) Copyright © 2003 International Society of Nephrology Terms and Conditions